Finance

Beta
Lists
RKV:CVE
Rakovina Therapeutics Inc
CA$0.14
0.00%
(0.00) 1D
Jun 3, 3:59:23 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for RKV...
Mkt. cap
3.30M
Avg. vol.
19.58K
Volume
67.00
52-wk high
CA$0.84
52-wk low
CA$0.08
EPS
-CA$0.48
Beta
0.42
Shares outstanding
21.15M
Mkt. cap
3.30M
Avg. vol.
19.58K
Volume
67.00
52-wk high
CA$0.84
52-wk low
CA$0.08
EPS
-CA$0.48
Beta
0.42
Shares outstanding
21.15M
News stories
From sources across the web
About Rakovina Therapeutics Inc
CEO-
Employees-
Founded2019
HeadquartersVancouver, British Columbia, Canada
SectorBiotechnology
Websiterakovinatherapeutics.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
885.59K
1.61M
1.10M
828.93K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.22M
1.21M
539.17K
972.87K
Operating expense
2.11M
2.83M
1.64M
1.80M
Total operating expenses
2.11M
2.83M
1.64M
1.80M
Operating income
-2.11M
-2.83M
-1.64M
-1.80M
Other non operating income
-
-
-
1.00
EBT including unusual items
-2.18M
-2.92M
-1.78M
-1.89M
EBT excluding unusual items
-2.18M
-2.92M
-1.78M
-1.91M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.18M
-2.92M
-1.78M
-1.89M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
773.00
Interest expense
-66.78K
-91.69K
-139.75K
-108.48K
Net interest expenses
-66.78K
-91.69K
-139.75K
-107.70K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.98M
-2.69M
-1.51M
-1.67M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer